ADx NeuroSciences focuses on the development of novel (bio)markers for use in dementia diagnosis (Dx) Alzheimer’s (AD), Parkinson’s and other neurodegenerative diseases and companion diagnostics. ADx NeuroSciences builds on its leading expertise, development know-how and capabilities to offer innovative solutions - from concept to clinical value - for Pharma and IVD.
Location: Belgium, East Flanders, Ghent